91 – 100 of 620
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Site-specific CRISPR-based mitochondrial DNA manipulation is limited by gRNA import
- Contribution to journal › Article
-
Mark
Stem cells, cell therapies, and bioengineering in lung biology and disease 2021
- Contribution to journal › Scientific review
-
Mark
HMGA1 has predictive value in response to chemotherapy in gastric cancer
- Contribution to journal › Article
-
Mark
Genome-wide association study on 13 167 individuals identifies regulators of blood CD34+cell levels
- Contribution to journal › Article
-
Mark
Inducing synthetic lethality for selective targeting of acute myeloid leukemia cells harboring STAG2 mutations
- Contribution to journal › Letter
-
Mark
Small Molecule Screening of Primary Human Acute Myeloid Leukemia Using Co-culture and Multiplexed FACS Analysis
- Contribution to journal › Article
-
Mark
A somatic mutation in moesin drives progression into acute myeloid leukemia
- Contribution to journal › Article
-
Mark
Reprogramming Stars #6 : A Venture Based in Cellular Reprogramming-An Interview with Dr. Cristiana Pires
- Contribution to journal › Debate/Note/Editorial
-
Mark
Reprogramming Stars #5 : Regeneration, a Natural Reprogramming Process-An Interview with Dr. Nicholas Leigh
- Contribution to journal › Debate/Note/Editorial
-
Mark
Compositions, constructs and vectors for cell reprogramming (NK cell reprogramming).
(2022) WO2022129542
- Patent › Patent
